Company Filing History:
Years Active: 2011
Title: Innovations in Cancer Treatment by Krishna Juluri
Introduction
Krishna Juluri is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer research through his innovative work on anti-cancer drugs. His research focuses on the regulation of cell survival, which is crucial for developing effective cancer treatments.
Latest Patents
Krishna Juluri holds a patent titled "Regulation of cell survival by HSP90 and IP6K2." This patent outlines a method for identifying anti-cancer drugs by screening for agents and compounds that inhibit the binding of HSP90 and IP6K2. The patent emphasizes the use of in vitro and in vivo assays to monitor various phenomena associated with the binding or inhibition, including cell death, subcellular localization, catalytic activity of IP6K2, and IP7 formation.
Career Highlights
Krishna Juluri is affiliated with The Johns Hopkins University, where he continues to advance his research in cancer treatment. His work has garnered attention for its potential to lead to new therapeutic strategies for combating cancer.
Collaborations
Some of his notable coworkers include Solomon H Snyder and Anutosh Chakraborty. Their collaborative efforts contribute to the innovative research environment at The Johns Hopkins University.
Conclusion
Krishna Juluri's contributions to cancer research through his patent and work at The Johns Hopkins University highlight the importance of innovation in developing new treatments. His research has the potential to significantly impact the field of oncology and improve patient outcomes.